Aptinyx Inc. (APTX): Price and Financial Metrics


Aptinyx Inc. (APTX)

Today's Latest Price: $3.55 USD

0.08 (2.31%)

Updated Feb 18 8:00pm

Add APTX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 215 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

APTX Stock Summary

  • APTX's went public 1.66 years ago, making it older than only 2.63% of listed US stocks we're tracking.
  • The ratio of debt to operating expenses for Aptinyx Inc is higher than it is for about only 0.37% of US stocks.
  • APTX's price/sales ratio is 31.64; that's higher than the P/S ratio of 95.84% of US stocks.
  • Stocks that are quantitatively similar to APTX, based on their financial statements, market capitalization, and price volatility, are AGTC, IMGN, CLDX, SGMO, and SURF.
  • APTX's SEC filings can be seen here. And to visit Aptinyx Inc's official web site, go to www.aptinyx.com.
APTX Daily Price Range
APTX 52-Week Price Range

APTX Stock Price Chart More Charts


APTX Price/Volume Stats

Current price $3.55 52-week high $6.00
Prev. close $3.47 52-week low $2.61
Day low $3.46 Volume 121,000
Day high $3.59 Avg. volume 456,806
50-day MA $3.85 Dividend yield N/A
200-day MA $3.54 Market Cap 155.65M

Aptinyx Inc. (APTX) Company Bio


Aptinyx Inc. develops therapeutics for neurological disorders. The company is focused on the development of drugs that interact with the NMDA receptor, and the company says it will use the funds to advance drugs for chronic pain, post-traumatic stress disorder (PTSD) and cognitive impairment in Parkinson’s disease. The company was founded in 2015 and is based in Evantson, Illinois.


APTX Latest News Stream


Event/TimeNews Detail
Loading, please wait...

APTX Latest Social Stream


Loading social stream, please wait...

View Full APTX Social Stream

APTX Price Returns

1-mo N/A
3-mo 10.94%
6-mo 18.33%
1-year -36.04%
3-year N/A
5-year N/A
YTD 3.80%
2019 -79.32%
2018 N/A
2017 N/A
2016 N/A
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.5962 seconds.